pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Atorvastatin Calcium
drug
save

atorvastatin

Marketedupdated 3mo ago
by Laurus Labs Ltd
Approved
annual revenue · 2024–2024peak $1.8B
2024: $1.8B2024$1.8B
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval32 co-mentions · 16 sources
  • drugatorvastatin calcium21 co-mentions · 21 sources
  • drugLipitor21 co-mentions · 21 sources
  • tagSmall Molecule16 co-mentions · 16 sources
  • companyAscend Laboratories Ltd8 co-mentions · 4 sources
  • tagRecall5 co-mentions · 5 sources
  • companyAlkem Laboratories Ltd4 co-mentions · 4 sources
  • companyBiocon Pharma Ltd2 co-mentions · 1 sources

indications

investigational
Hyperlipidemia

all catalysts(0)

nothing on the calendar yet

Trials studying atorvastatin

  • —A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemiarecruitingn=2,000
  • phase2Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)recruitingn=352
  • phase3A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Eventsnot yet recruitingn=103
  • phase3A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVIDnot yet recruitingn=252
  • phase1A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participantsrecruitingn=16
  • phase1A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weightcompletedn=34
  • phase2Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.suspendedn=40
  • phase1A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participantsnot yet recruitingn=40
more trials →

News(0)

no news has mentioned this drug yet

brand
Atorvastatin Calcium
generic
atorvastatin [INN]
indication
Cardiovascular Risk Factors
phase
marketed
approved
1996-12-17
Data sources
openFDA · ClinicalTrials.gov
last refreshed 51m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?